Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Non-Monotonic Survival of Staphylococcus aureus with Respect to Ciprofloxacin Concentration Arises from Prophage-Dependent Killing of Persisters.

Sandvik EL, Fazen CH, Henry TC, Mok WW, Brynildsen MP.

Pharmaceuticals (Basel). 2015 Nov 17;8(4):778-92. doi: 10.3390/ph8040778.

2.

The role of metabolism in bacterial persistence.

Amato SM, Fazen CH, Henry TC, Mok WW, Orman MA, Sandvik EL, Volzing KG, Brynildsen MP.

Front Microbiol. 2014 Mar 3;5:70. doi: 10.3389/fmicb.2014.00070. eCollection 2014. Review.

3.

Direct electric current treatment under physiologic saline conditions kills Staphylococcus epidermidis biofilms via electrolytic generation of hypochlorous acid.

Sandvik EL, McLeod BR, Parker AE, Stewart PS.

PLoS One. 2013;8(2):e55118. doi: 10.1371/journal.pone.0055118. Epub 2013 Feb 4.

4.

Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.

Hegde LG, Yu C, Renner T, Thibodeaux H, Armstrong SR, Park T, Cheruvu M, Olsufka R, Sandvik ER, Lane CE, Budman J, Hill CM, Klein U, Hegde SS.

J Cardiovasc Pharmacol. 2011 Apr;57(4):495-504. doi: 10.1097/FJC.0b013e318210fc7e.

PMID:
21297495
5.
6.

Gender differences in the prevalence and determinants of the metabolic syndrome in screened subjects at risk for coronary heart disease.

Tonstad S, Sandvik E, Larsen PG, Thelle D.

Metab Syndr Relat Disord. 2007 Jun;5(2):174-82. doi: 10.1089/met.2006.0037.

PMID:
18370825
7.

Effect of nurse counselling on metabolic risk factors in patients with mild hypertension: a randomised controlled trial.

Tonstad S, Alm CS, Sandvik E.

Eur J Cardiovasc Nurs. 2007 Jun;6(2):160-4. Epub 2006 Aug 17.

PMID:
16914379
8.

Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.

Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE Jr, Gao Q, Cass RT, Karr DE, Benton BM, Humphrey PP.

Antimicrob Agents Chemother. 2005 Mar;49(3):1127-34.

9.

[Stovner district--14 years with the green prescription].

Steihaug S, Ahlsen B, Eide W, Tjønneland AE, Refsnes KA, Kjaer B, Sandvik E.

Tidsskr Nor Laegeforen. 2005 Feb 3;125(3):310-1. Norwegian. No abstract available.

10.

Predictors for the white coat effect in general practice patients with suspected and treated hypertension.

Lindbaek M, Sandvik E, Liodden K, Mjell J, Ravnsborg-Gjertsen K.

Br J Gen Pract. 2003 Oct;53(495):790-3.

12.
13.

[Membership in Norwegian Nurses' Association at any cost?].

Gausemel J, Sylte GD, Sandvik EM, Torske M, Nordkvist S, Børset E, Naas R, Solemdal H, Sønderland O, Rønningen J, Fure L, Saether G, Nistad I, Kvisterød G, Gravdehaug EA, Gagnet AE, Bratset L.

Tidsskr Sykepl. 1998 Mar 10;86(5):5-6. Norwegian. No abstract available.

PMID:
9544118
14.

[Home blood pressure measurement in general practice patients].

Sandvik E, Steine S, Kjeldsen S.

Tidsskr Nor Laegeforen. 1996 Sep 10;116(21):2566-9. Norwegian.

PMID:
8928127
15.

Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension.

Seljeflot I, Moan A, Kjeldsen S, Sandvik E, Arnesen H.

Hypertension. 1996 Jun;27(6):1299-304.

PMID:
8641739
16.

Gender differences in negative affect and well-being: the case for emotional intensity.

Fujita F, Diener E, Sandvik E.

J Pers Soc Psychol. 1991 Sep;61(3):427-34.

PMID:
1941513
17.

Further validation of the Satisfaction with Life Scale: evidence for the cross-method convergence of well-being measures.

Pavot W, Diener E, Colvin CR, Sandvik E.

J Pers Assess. 1991 Aug;57(1):149-61.

PMID:
1920028
18.

[Compliance--multimedication and the elderly].

Sandvik E, Braaten E.

Tidsskr Nor Laegeforen. 1986 Jun 20;106(17-18):1467-8. Norwegian. No abstract available.

PMID:
3764814

Supplemental Content

Loading ...
Support Center